Stage 2 Stocks in Financial Data & Stock Exchanges
6 US stocks in Financial Data & Stock Exchanges are in Stage 2, the advancing phase of Weinstein's stage analysis. Listed below: those priced at $5 or more and trading at least $1 million a day on average, ranked by setup score and updated after every close (last close Oct 23, 2026).
| Stock | Close | 1D | Setup | Weeks in stage |
|---|---|---|---|---|
| FDS FactSet Research Systems Inc. | $331.32 | -1.23% | 8.0 | 12 |
| MORN Morningstar, Inc. | $224.89 | +0.70% | 6.6 | 8 |
| NDAQ Nasdaq, Inc. | $102.56 | -0.72% | 6.1 | 10 |
| ICE Intercontinental Exchange Inc. | $162.74 | -0.67% | 6.0 | 4 |
| CME CME Group Inc. Class A | $305.71 | -0.09% | 6.0 | 1 |
Financial Data & Stock Exchanges: quick answers
Which stocks in Financial Data & Stock Exchanges are in an uptrend?
As of Oct 23, 2026, 6 US stocks in Financial Data & Stock Exchanges are in Stage 2, the uptrend phase. They are CME Group, Intercontinental Exchange, Nasdaq, FactSet Research Systems and Morningstar.
How many stocks in Financial Data & Stock Exchanges are in Stage 2?
6 of the 13 stocks we track in Financial Data & Stock Exchanges (46.1%) are in Stage 2. 1 is basing in Stage 1, 4 are topping in Stage 3 and 2 are in a Stage 4 downtrend. That share has fallen 7.7 points over the last 20 sessions.
Which stocks in Financial Data & Stock Exchanges entered Stage 2 recently?
2 stocks entered Stage 2 in the last four weeks: CME Group (its first week) and Intercontinental Exchange (week 4).
Daily screens
Every one recalculated after the close, with the exact criteria published on the page.
Stage 2 in other sectors & industries
US stocks in a confirmed uptrend (Stage 2, Weinstein’s advancing phase), grouped by sector and industry and ranked by setup score.